Brian Rosenberger
Preparing clinical-stage companies for launch, portfolio strategy, and M&A.
About Brian
Brian Rosenberger is a commercial strategy, business development, and growth executive with deep experience helping biopharmaceutical organizations prepare clinical-stage assets and companies for commercialization, strategic partnering, and M&A opportunities. He operates at the intersection of commercial strategy, business development, and organizational growth, helping companies strengthen launch readiness, evaluate strategic opportunities, and align cross-functional teams around long-term value creation. His experience includes U.S. and global commercial leadership, business development, alliance management, portfolio strategy, licensing, mergers and acquisitions, analytics, and lifecycle management spanning clinical-stage development through launch and loss of exclusivity. Brian has worked extensively with biotech start-ups and specialty pharmaceutical organizations across CNS, urology, endocrinology, dermatology, orthopedics, and infectious disease/HIV, supporting organizations during periods of growth, commercialization, and strategic transition. Today, Brian partners with life sciences companies navigating commercialization planning, ex-U.S. partnering, growth strategy, and corporate development initiatives, helping organizations position assets, strengthen strategic alignment, and drive measurable enterprise value.